Rigel Pharmaceuticals
RIGL
#6656
Rank
A$1.14 B
Marketcap
A$60.57
Share price
-2.67%
Change (1 day)
-15.37%
Change (1 year)

Earnings for Rigel Pharmaceuticals (RIGL)

Earnings in 2026 (TTM): A$0.13 Billion

According to Rigel Pharmaceuticals's latest financial reports the company's current earnings are A$0.27 Billion. In 2025 the company made an earning of A$0.19 Billion, an increase over its 2024 earnings that were of A$39.7 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Rigel Pharmaceuticals from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) A$0.13 B-30.68%
2025 A$0.19 B391.35%
2024 A$39.7 M-244.27%
2023 -A$27.53 Million-66.79%
2022 -A$82.9 Million340.73%
2021 -A$18.81 Million-56.15%
2020 -A$42.9 Million-57.34%
2019 -A$0.11 Billion-7.66%
2018 -A$0.11 Billion-9.47%
2017 -A$0.13 Billion24.46%
2016 -A$96.65 Million23.63%
2015 -A$78.18 Million-43.29%
2014 -A$0.14 Billion2.5%
2013 -A$0.14 Billion
2010 A$57.19 M-133.97%
2009 -A$0.17 Billion-18.49%
2008 -A$0.21 Billion71.91%
2007 -A$0.13 Billion84.74%
2006 -A$65.04 Million-10.17%
2005 -A$72.41 Million-15.73%
2004 -A$85.92 Million39.29%
2003 -A$61.69 Million10.3%
2002 -A$55.93 Million48.3%
2001 -A$37.72 Million-2.13%
2000 -A$38.54 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amgen
AMGN
A$16.69 B 11,994.42%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$22.79 B 16,412.19%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sangamo Therapeutics
SGMO
-A$0.17 Billion-220.73%๐Ÿ‡บ๐Ÿ‡ธ USA
ChemoCentryx
CCXI.defunct
-A$0.2 Billion-242.92%๐Ÿ‡บ๐Ÿ‡ธ USA